Press Coverage

Endomicroscopy system could increase detection of esophageal dysplasia, cancer

13 July 2022

A meta-analysis found that using Cellvizio — a multidisciplinary probe and needle-based confocal laser endomicroscopy system — in tandem with the standard of care to guide biopsies improves diagnosis for dysplasia and cancer and reduces sampling error, according to research published in Techniques and Innovations in Gastrointestinal Endoscopy.

Latest News

Publication of the 2025 Annual Financial Report 

Publication of the 2025 Annual Financial Report 

Mauna Kea Technologies Announces Expanded Clinical Evidence for Cellvizio® To Be Presented at Digestive Disease Week® 2026 

Mauna Kea Technologies Announces Expanded Clinical Evidence for Cellvizio® To Be Presented at Digestive Disease Week® 2026 

Mauna Kea Technologies Reports FY 2025 Financial Results: Comprehensive Debt Restructuring and Reaccelerating Organic Growth Mark a Transformative 2025 

Mauna Kea Technologies Reports FY 2025 Financial Results: Comprehensive Debt Restructuring and Reaccelerating Organic Growth Mark a Transformative 2025 

No results found.